ArticleCancers2024

Treatment, Prognostic Markers, and Survival in Thymic Neuroendocrine Tumors, with Special Reference to Temozolomide-Based Chemotherapy.

Zixuan Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.